Shareholders of agilon health, inc. Should Contact Levi & Korsinsky Before March 2, 2026 to Discuss Your Rights - AGL [Accessibility Statement] Skip NavigationNEW YORK, Feb. 25, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc." or the "Company") (NYSE: AGL) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of agilon health, inc. investors who were adversely affected by alleged securities fraud betwee ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Agilon health To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Agilon health between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - Fe ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options If you purchased or acquired Agilon securities between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- What’s Happening? Brag ...

New York, New York--(Newsfile Corp. - February 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.SO WHAT: If you purchased agilon securities during the Class Period you may be entitled to compensation without payment of any ou ...

Core Viewpoint - Agilon Health, Inc. is facing a class action lawsuit for securities law violations, specifically for making false and misleading statements regarding its financial guidance and strategic actions [1] Group 1: Lawsuit Details - The class action lawsuit is based on violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1] - The class period for the lawsuit is from February 26, 2025, to August 4, 2025, with a deadline for lead plaintiff appointment on March 2, 2026 [1] - The complaint alleges that Agilon's 2026 guidance was unattainable, which the company was aware of when communicating with investors [1] Group 2: Company Misrepresentation - Agilon is accused of overstating the impact of its "strategic actions" intended to mitigate risk [1] - The lawsuit claims that Agilon's public statements were false and materially misleading throughout the class period [1]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased agilon health, inc. securities between February 26, 2025, and August 4, 2025, about the March 2, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased agilon securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - To serve as lead plaintiff, individuals must file a motion with the Court by March 2, 2026 [3]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and reputation [4]. Group 3: Case Allegations - The lawsuit alleges that defendants made false or misleading statements and failed to disclose critical information regarding agilon's financial guidance for 2025, which was deemed unachievable due to known industry challenges [5]. - It is claimed that defendants overstated the positive financial impact of strategic actions taken by agilon, leading to materially false statements about the company's business and prospects [5]. - The lawsuit asserts that when the true information became public, investors suffered damages as a result [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased agilon health, inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who bought agilon securities between February 26, 2025, and August 4, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by March 2, 2026 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Allegations Against Agilon - The lawsuit alleges that during the Class Period, defendants made false and misleading statements and failed to disclose critical information, including: 1. Reckless issuance of guidance for 2025 that was unlikely to be achieved due to known industry challenges 2. Material overstatement of the financial impact from strategic actions taken by agilon to mitigate risk 3. Overall misleading statements regarding agilon's business, operations, and prospects [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. due to allegations of violations of federal securities laws, particularly regarding misleading statements and guidance related to the company's financial performance [2][4]. Group 1: Legal Investigation and Claims - The firm is encouraging investors who suffered losses in agilon health between February 26, 2025, and August 4, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against agilon health, with a deadline of March 2, 2026, for investors to seek the role of lead plaintiff [2]. - The complaint alleges that agilon health and its executives made false statements and failed to disclose significant industry challenges, leading to misleading information about the company's business and financial outlook [4]. Group 2: Financial Impact and Stock Performance - On August 4, 2025, agilon health announced the suspension of its full-year 2025 financial guidance, citing more severe industry headwinds than previously anticipated [5]. - Following this announcement, agilon health's stock experienced a significant decline of 51.5% on August 5, 2025 [5]. Group 3: Firm Background and Encouragement for Whistleblowers - Faruqi & Faruqi, LLP has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [3]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding agilon health's conduct [7].

Agilon Health Deadline: AGL Investors with Losses in Excess of $100K Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm [Accessibility Statement] Skip NavigationNEW YORK, Feb. 20, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff ...

Core Viewpoint - A class action lawsuit has been filed against agilon health, inc. for allegedly making false statements and failing to disclose critical information regarding its financial guidance and the impact of strategic actions taken by the company [4]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased agilon securities between February 26, 2025, and August 4, 2025, alleging that the company issued misleading guidance for 2025 despite being aware of significant industry challenges [4]. - The lawsuit claims that agilon overstated the positive financial impact from its strategic actions aimed at reducing risk [4]. Group 2: Company Events - On August 4, 2025, agilon announced the resignation of its President and CEO, Steven Sell, which was classified as a termination without cause [5]. - The same day, agilon reported its second-quarter results and acknowledged that industry headwinds were more severe than previously anticipated, leading to the suspension of its full-year 2025 financial guidance [5]. - Following these announcements, agilon's stock price fell by $0.94, or approximately 51.6%, from $1.82 to $0.88 per share [5].